Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an update.
NeuroScientific Biopharmaceuticals Ltd has announced a change in its registered and principal office address, now located at Level 4, 216 St Georges Terrace, Perth, Western Australia 6000. This operational update includes a change in the company’s contact number, reflecting administrative adjustments to streamline operations.
More about Neuroscientific Biopharmaceuticals Ltd.
NeuroScientific Biopharmaceuticals Ltd operates in the biopharmaceutical industry, focusing on developing neurological drugs and therapies. The company aims to address unmet medical needs in neurological disorders through innovative treatments.
YTD Price Performance: 30.0%
Average Trading Volume: 133,789
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.64M
For a thorough assessment of NSB stock, go to TipRanks’ Stock Analysis page.
